We measured pre-and post-dialysis concentrations of ionized calcium (iCa) in whole blood, total calcium (tCa) in plasma, and intact parathyrin (PTH) in serum of 19 patients undergoing maintenance hemodialysis. Plasma tCa was inappropriately increased relative to iCa in 63% of the specimens; the iCa correlated with the PTH concentration in 12 of 19 pre-dialysis specimens, whereas tCa correlated with PTH in only five patients. During dialysis, 16 patients had analytically significant changes in iCa (i.e., exceeded the analytical imprecision of 0.04 mmol/L). Pre-and post-dialysis concentrations of PTH were normal in six patients, four of whom showed a detectable response to changes in iCa. Ten patients had increased PTH in at least one specimen; of these, eight had responsive parathyroid glands. Five of the 16 patients had an increased set point for calcium. The minimal PTH responses of two patients suggested refractory hyperparathyroidism. We conclude that routine estimation of iCa, rather than tCa, in dialysis patients markedly improves the identification of patients at risk for secondary hyperparathyroidism, and that measurement of intact PTH in pre-and post-dialysis serum offers a simple means of assessing parathyroid responsiveness in dialysis patients. Calcium loading and depletion have been used to study PTH response in normal subjects (3, 4) and patients with renal failure (5, 6). In such studies, an oral dose of calcium is given, or calcium gluconate is infused at a constant rate for 2 h. Because such studies are cumbersome for routine assessment of parathyroid activity in dialysis patients, clinicians rely on various other tests, e.g., increased serum PTH concentrations (midmolecule, C-terminal, or intact PTH), increased total alkaline phosphatase (EC 3.1.3.1) activity, and histological evidence of osteodystrophy.
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AdditIonal Keyphrases: total and ionizedcalcium
The response of normal parathyroids to changes in iCa is rapid (<5 mm) and, because the half-life of the biologically active intact PTH is short (<10 mm), any marked change in iCa will induce a rapid change in serum PTH. The intact PTH molecule is too large to cross the hemodialysis membrane; therefore, for patients receiving hemodialysis, changes in plasma concentrations of iCa during dialysis should result in detectable and appropriate changes in intact PTH circulating in serum if the parathyroids are still functional. The recent intrOduction of assays specific for the physiologically active intact PTH allowed us to investigate whether the measurement of intact P'FH in pre-and post-dialysis serum specimens from patients on longterm hemodialysis would be useful in assessing parathyroid responsiveness and identifying patients with refractory parathyroid glands.
Patients and Methods

Patients
We selected 19 patients with chronic renal failure who were undergoing maintenance hemodialysis in the Renal Unit at Flinders Medical Centre. One patient had had a partial parathyroidectomy seven years before our study. The patients and the Senior Consultant gave informed consent. Patients had not ingested aluminum hydroxide for five months before the study. Only two patients ( 
Methods
Venous blood (10 mL) was taken from the patients immediately before and after each routine hemodialysis treatment. Blood was collected in 10-mL tubes contain- 
Results
The results for tCa, actual iCa, and intact PTH obtained for each patient, both pro -(a) and post-(b) dialysis, are shown in Table 1 with the relevant clinical information.
Total and Ionized Calcium
For all samples analyzed, we compared tCa and iCa values with their respective reference intervals and found that the clinical interpretations (e.g., low, normal, increased) did not concur in 24 of the 38 results (63%) ( Table 1 ). The tCa:iCa ratio was increased in all discrepant cases. In the pre-dialysis samples, iCa and tCa did not concur in 10 of the 19 specimens (Figure 1, left) 1; patients 8a, 14a, iSa,  18a, and 19a) . In seven other patients, the tCa value was misleading relative to the PTH value, whereas the iCa value was appropriate. In the remaining samples, iCa and tCa were either both normal or increased and discrepant with the PTH (patients 4a, 5a, 7a, and lOa), or conflicted both with each other and the PTH value (patients la, ha, and 12a).
For the pre-dialysis samples, we identified four patterns of relationship between iCa and PTH (Figure 1,  right) . Twelve patients had either low, normal, or increased iCa values associated with high, normal, or low PTH values, respectively, as would be expected. In patients la, 7a, and lOa, the iCa was within the reference interval in association with an increased PTH, suggesting either an increased set point for iCa or an iCa below the normal set point of that individual. Two other patients appeared to have hyporesponsive parathyroid glands (patients ha and 12a). The remaining two patients (patients 4a, 5a) had increased iCa and PTH, suggestive of an increased set point for calcium.
PTH Responses to Dialysis
The log of the pro -and post-dialysis concentration of serum PTH vs the matching iCa concentration for each patient is shown in Figure 2 . Three patients (patients 17-19) had a change in iCa of less than the analytical imprecision of 0.04 mmol/L (2.8 x SD) and were excluded.
P'H concentrations of six patients (patients 11-16) remained below the upper limit of the reference interval, both pro -and post-dialysis, although iCa values were outside the reference interval either pro-or post- iCaand increased PTH a bone biopsy indicated moderate osteitis fibrosa with extensive but incomplete aluminum block. As previously noted, two of these patients (patients 4 and 5) showed evidence of altered iCa set points for PTH suppression, whereas the response to dialysis suggests that patients 1-3 should be similarly classified. Even though the pre-and post-dialysis iCa in patients 2 and 3 were low or low normal, their increased concentrations of serum PTH and the slopes of the PTH response to changes in iCa during dialysis suggest that they would not suppress P'FH secretion to normal values, even at increased iCa concentrations. However, such patients would require PTH testing before and alter a dialysis that increased their iCa concentration.
DiscussIon
Patients receiving regular hemodialysis for chronic renal failure will develop metabolic bone disease, particularly if concentrations of plasma PTH remain above normal for long periods.
Therefore, the prevailing plasma iCa concentration must be maintained within the range that suppresses PTH to within normal limits. Apart from the pathological effects of renal failure on calcium homeostasis, concentrations of plasma calcium may also be disturbed by calcium salts administered as a therapeutic measure to decrease phosphate concentrations. The dialysis procedure provides the means by which the plasma calcium concentration of the patient can be adjusted to minimize the likelthood of markedly increased P'FH.
Although iCa is the major regulator of PTH release, the more readily measured tCa provides a useful indicator of the associated ionized fraction, with a rule-ofthumb correction applied sometimes if the albumin concentration is markedly abnormal. Therefore, laboratories generally measure tCa (the sum of the albuminbound and ionized fractions) to monitor pro-and postdialysis concentrations of plasma calcium. However, various anionic substances that bind calcium are increased in the plasma of patients with chronic renal failure (e.g., phosphate, sulfate) (8) such that the usual relationship (9) between tCa and iCa is often disturbed, leading to an increased tCa:iCa ratio.
In this study, nearly two-thirds of the iCa and the tCa results were discordant in their interpretation. Renal physicians are aware of the inappropriateness of applying the usual calcium reference intervals to dialysis patients, and that results for tCa may be misleading. Thus, during dialysis, physicians often aim to achieve high normal or slightly increased tCa values to minimize the PTH increase, without exceeding the solubility product of calcium and phosphate. In this study, the pre-dialysis tCa reflected the prevailing PTH value in only five of the 19 patients, whereas iCa did so in 12 patients. Our study suggests that laboratories should make iCa measurements more routinely available to dialysis units.
A major aim of this study was to determine whether dialysis-induced changes in iCa would lead to diagnostically informative changes in PTH concentrations. In the majority of patients, an analytically significant change in iCa was achieved without calcium loading during a standard dialysis treatment.
Interpretation of the responses of PTH to these changes is complicated by both the sigmoidal relationship between iCa and PTH in apparently healthy subjects (2) and the sensitivity of the PTH assay. Within these limitations, we found that all but four patients demonstrated some parathyroid responsiveness to an altered iCa. Five patients showed evidence of an increased set point for iCa, but all showed a PTH response to an alteration in iCa. Of the nine patients with increased pro-dialysis P'FH, in only one was PTH normalized by a dialysis-induced increase of iCa. The response of patients 1 and 2 was inadequate and suggestive of refractory parathyroids; both patients also had histological evidence of osteitis fibrosa. Subsequently, one of these patients had a partial parathyroidectomy, and the other had a renal transplant with improved parathyroid function. The PTH slopes obtained for three, possibly four, other patients (patients 3, 6, 7, 10) suggest that P'FH might be capable of normalization and that it would be worth retesting for PTH concentrations during a future dialysis session if the post-dialysis iCa concentration was greater than in this study.
Our patients with an increased calcium set point had been on hemodialysis for longer (mean 4.7 years, range 1-12 years) than those with a normal set point (mean 1.5 years, range 0.25-4 years), suggesting that the altered set point may be related to length of time on dialysis.
If an increased calcium set point for PTH suppression develops with time, and an increased set point is associated with a future risk of refractory parathyroids, then the five patients identified as having parathyroid glands still responsive to iCa changes but with an increased calcium set point may be at greater risk of developing refractory hyperparathyroidism than those with a normal calcium set point. Measurement of the total alkaline phosphatase activity in plasma in our patients was not helpful in assessing whether the parathyroids were becoming less responsive.
In conclusion, our findings suggest that routine mea- with chronic renal failure. We also suggest that quantification of pre-and post-dialysis concentrations of intact PTH at regular intervals, where considerable changes in plasma iCa occur during dialysis, is a useful and simple diagnostic tool to help detect and assess refractory hyperparathyroidism in chronic renal failure patients on long-term hemodialysis. We plan to investigate the reproducibility of these observations in the near future.
